...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Novel phospholipid analogues of pan-PPAR activator tetradecylthioacetic acid are more PPARalpha selective.
【24h】

Novel phospholipid analogues of pan-PPAR activator tetradecylthioacetic acid are more PPARalpha selective.

机译:Pan-PPAR活化剂十四乙酰硫代乙酸的新型磷脂类似物更抗抗抗氨抗性。

获取原文
获取原文并翻译 | 示例
           

摘要

Tetradecylthioacetic acid (TTA) is a modified fatty acid that appears to improve insulin sensitivity, lower blood lipid levels, enhance fatty acid oxidation and promote anti-inflammatory action in vivo, through mechanisms partly dependent upon peroxisome proliferator-activated receptors (PPARs). In order to improve the biological efficacy of TTA as a PPAR agonist, two novel phospholipid analogue lyso tetradecylthioacetyl-L-alpha-phosphatidylcholine and di-tetradecylthioacetyl-L-alpha-phosphatidylglycerol have been developed. Here we report on the syntheses of these novel phospholipids and their relative potential to act as PPAR agonists in vitro, in comparison to TTA and other positive controls.
机译:十四烷基硫酸(TTA)是一种改性脂肪酸,其似乎改善胰岛素敏感性,降低血脂水平,增强脂肪酸氧化和促进体内抗炎作用,通过部分依赖于过氧化物体增殖物激活的受体(PPAR)。 为了提高TTA作为PPAR激动剂的生物学效果,已经开发出两种新型磷脂类似物溶胶四乙酰基-1-磷脂酰胆碱和二十四烷基硫代乙酰基-1-磷脂酰甘油。 在这里,我们报道了与TTA和其他阳性对照相比,这些新型磷脂和它们作为PPAR激动剂充当PPAR激动剂的相对潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号